Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Published March 31, 2016
N Engl J Med 2016;374:1253-1263
DOI: 10.1056/NEJMra1507771
Abstract
The epidemic of opioid abuse is related in part to incomplete understanding of pain-relief management, opioid tolerance, and opioid addiction. Among the prevention strategies are more widespread sharing of data about opioid neuropharmacology and opioid-use patterns.
Access this content
Select an option below:
Create your account for free access to subscriber-only content.
Get Free Access Now Subscribe For Full AccessAlready have an account?
Sign In
Print subscriber?
Activate your online access
Interested in purchasing this article?
BUY NOW FOR $55
Are you a member of an institution such as a university or hospital?Learn more about Institutional Access
Notes
Dr. McLellan reports receiving fees for serving on the board of directors of Indivior Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
Supplementary Material
Information & Authors
Information
Published In
Editor
Dan L. Longo, M.D., Editor
Copyright
Copyright © 2016 Massachusetts Medical Society. All rights reserved.
For personal use only. Any commercial reuse of NEJM Group content requires permission.
History
Published online: March 31, 2016
Published in issue: March 31, 2016
Topics
Authors
Affiliations
From the National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD (N.D.V.); and the Treatment Research Institute, Philadelphia (A.T.M.).
Metrics & Citations
Metrics
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Discovery, SAR, and molecular basis of (R)-1-((3R,4S)-3-((dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-3-(3-fluorophenyl)-2-methylpropan-1-one as a novel potent analgesic, Bioorganic & Medicinal Chemistry, 132, (118474), (2026).https://doi.org/10.1016/j.bmc.2025.118474
- The balance of pain treatment and pain facilitation by opioids: Relevance for opioid use disorder risk, New Opioid Receptor Modulators and Agonists, (51-61), (2026).https://doi.org/10.1016/B978-0-443-26504-4.00018-1
- Stakeholder perspectives on the reduction of opioid exposure in ICU: A modified Delphi survey, Intensive and Critical Care Nursing, 91, (104089), (2025).https://doi.org/10.1016/j.iccn.2025.104089
- Use patterns of classic, novel, and herbal opioids, Emerging Trends in Drugs, Addictions, and Health, 5, (100166), (2025).https://doi.org/10.1016/j.etdah.2024.100166
- Pharmacology of Pain Management, Nursing Clinics of North America, 60, 4, (591-618), (2025).https://doi.org/10.1016/j.cnur.2025.01.005
- The Effects of Psychological Treatments for Chronic Pain on Reducing Opioid Use in People at Risk for Opioid Misuse: A Randomized Feasibility Trial, Pain Practice, 26, 1, (2025).https://doi.org/10.1111/papr.70107
- Physician Opioid Prescribing Attitudes in Michigan: An Exploratory Pilot Study of Age-Gender Interactions and the Awareness-Uncertainty Paradox, Cureus, (2025).https://doi.org/10.7759/cureus.96587
- Dexmedetomidine-Loaded Hydrogel Microneedles Alleviate Acute Inflammatory Visceral Pain in Mice, Gels, 11, 11, (904), (2025).https://doi.org/10.3390/gels11110904
- AMPK signaling in osteoarthritis: from mechanisms to targeted therapeutics, Frontiers in Pharmacology, 16, (2025).https://doi.org/10.3389/fphar.2025.1681610
- Opioid Deprescribing in Patients with Noncancer Pain, New England Journal of Medicine, 393, 18, (1833-1842), (2025)./doi/full/10.1056/NEJMcp2414789
- See more
Loading...